CMS Administrator Marilyn Tavenner pledged at a recent congressional hearing that the agency’s controversial proposal to eliminate some of the Medicare Part D protected classes will not be reintroduced on her watch.
“I’m not interested in bringing back the [Part D proposal regarding] drug categories,” Tavenner told the House Oversight and Government Reform Committee. Tavenner’s comments came in response to a question...